The International Vaccines Conference, a hybrid event taking place from November 17-19, 2025, in Singapore and online aims to be a central platform for unveiling the latest discoveries and developments in the field of vaccinology. The event emphasizes the critical role of vaccine innovation in protecting global health and combating infectious diseases. From foundational vaccine science to the newest technologies in vaccine delivery, attendees will gain insights into the advancements poised to shape healthcare in the coming decades.

Participants can look forward to sessions covering a diverse range of topics, including next-generation vaccine design, strategies for enhancing vaccine efficacy and durability, and solutions for equitable distribution. Special focus will be given to mRNA and viral vector vaccines that have transformed public health responses, as well as novel adjuvants and delivery systems that enhance immune responses and improve vaccine stability. Attendees will also explore the ongoing efforts to address vaccine hesitancy, particularly through community engagement and transparent communication strategies. With a hybrid format, the conference ensures accessibility and engagement for both on-site and virtual participants, creating a truly global dialogue.

We invite researchers, industry professionals, public health officials, policymakers, and students to be a part of this dynamic event. Join us to expand your network, exchange ideas, and contribute to a future where vaccine innovation can support healthier, more resilient societies worldwide. VACCINE 2025 is more than an event—it’s a movement towards a brighter, healthier tomorrow through collaborative efforts in vaccine science.

The Mathews Journal of Immunology & Allergy is proud to serve as the supporting journal for this upcoming event. As part of this collaboration, a DOI will be assigned to the conference proceedings book, ensuring the research and findings presented at the event are globally accessible and citable. Additionally, participants who wish to publish their full-length research articles have the opportunity to submit their manuscripts for consideration in the Mathews Journal of Immunology & Allergy. This is an excellent platform for researchers and professionals to share their contributions to the field, receive peer-reviewed recognition, and enhance the visibility of their work. Article processing charges are completely free, and submitted manuscripts will only be published after a thorough peer review by the journal's editorial team.

To submit your manuscript, please visit: https://www.mathewsopenaccess.com/journals/immunology-allergy/submit-manuscript. The journal welcomes high-quality papers that expand on the topics discussed during the event.